Evidence map›Paper›PMID 33887457›Full record

ArticleJournal of biomedical informatics2021

Building an OMOP common data model-compliant annotated corpus for COVID-19 clinical trials.

Yingcheng Sun, Alex Butler, Latoya A Stewart, Hao Liu, Chi Yuan, Christopher T Southard, Jae Hyun Kim, Chunhua Weng

Abstract read
In one paragraph

Article in Journal of biomedical informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Clinical Trial Design Innovations for Precision Medicine in Asthma.Advances in experimental medicine and biology · 2023
    Article
  4. Inclusion of social determinants of health improves sepsis readmission prediction models.Journal of the American Medical Informatics Association : JAMIA · 2022
    Article
  5. Combining human and machine intelligence for clinical trial eligibility querying.Journal of the American Medical Informatics Association : JAMIA · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingcheng SunDepartment of Biomedical Informatics, Columbia University, New York, NY, USA.
Alex ButlerDepartment of Biomedical Informatics, Columbia University, New York, NY, USA; Department of Medicine, Columbia University, New York, NY, USA.
Latoya A StewartVagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Hao LiuDepartment of Biomedical Informatics, Columbia University, New York, NY, USA.
Chi YuanDepartment of Biomedical Informatics, Columbia University, New York, NY, USA.
Christopher T SouthardVagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Jae Hyun KimDepartment of Biomedical Informatics, Columbia University, New York, NY, USA.
Chunhua WengDepartment of Biomedical Informatics, Columbia University, New York, NY, USA. Electronic address: chunhua@columbia.edu.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH) - HEAL SupplementU24TR001579 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, PAUL A., WILKINS, CONSUELO HOPKINS · 2016 to 2022
$34.1M
Bridging the Semantic Gap Between Research Eligibility Criteria and Clinical DataR01LM009886 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WENG, CHUNHUA · 2009 to 2020
$5.3M
Biomedical Data Translator Technical Feasibility Assessment and Architecture DesignOT3TR002027 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DUMONTIER, MICHEL, TATONETTI, NICHOLAS P · 2016 to 2019
$2.7M
NCATS NIH HHS OT3 TR002027NCATS NIH HHS U24 TR001579NCATS NIH HHS UL1 TR001873NLM NIH HHS R01 LM009886
6 · The paper itself

Abstract

Clinical trials are essential for generating reliable medical evidence, but often suffer from expensive and delayed patient recruitment because the unstructured eligibility criteria description prevents automatic query generation for eligibility screening. In response to the COVID-19 pandemic, many trials have been created but their information is not computable. We included 700 COVID-19 trials available at the point of study and developed a semi-automatic approach to generate an annotated corpus for COVID-19 clinical trial eligibility criteria called COVIC. A hierarchical annotation schema based on the OMOP Common Data Model was developed to accommodate four levels of annotation granularity: i.e., study cohort, eligibility criteria, named entity and standard concept. In COVIC, 39 trials with more than one study cohorts were identified and labelled with an identifier for each cohort. 1,943 criteria for non-clinical characteristics such as "informed consent", "exclusivity of participation" were annotated. 9767 criteria were represented by 18,161 entities in 8 domains, 7,743 attributes of 7 attribute types and 16,443 relationships of 11 relationship types. 17,171 entities were mapped to standard medical concepts and 1,009 attributes were normalized into computable representations. COVIC can serve as a corpus indexed by semantic tags for COVID-19 trial search and analytics, and a benchmark for machine learning based criteria extraction.

Indexed as

Clinical Trials as TopicComputer SimulationCOVID-19Eligibility DeterminationHumansMachine LearningPandemicsClinical trialCOVID-19Eligibility criteriaMachine readable datasetStructured text corpus

Identifiers

PMID33887457
PMCPMC8079156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.